Yunnan Baiyao Group Co.,Ltd (SHE:000538)

Market Cap	91.09B -13.4%
Revenue (ttm)	41.81B +2.4%
Net Income	5.22B +0.5%
EPS	2.92 +0.5%
Shares Out	1.78B
PE Ratio	17.47
Forward PE	15.90
Dividend	2.62 (5.13%)
Ex-Dividend Date	Sep 24, 2026

Volume	8,763,465
Open	50.20
Previous Close	51.39
Day's Range	50.20 - 51.40
52-Week Range	46.29 - 59.53
Beta	0.09
Analysts	Buy
Price Target	67.86 (+32.93%)
Earnings Date	Aug 29, 2026

About SHE:000538

Yunnan Baiyao Group Co.,Ltd engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China. The company offers health products; traditional Chinese medicine used for pain management and anti-inflammation, including the Yunnan Baiyao aerosol, Yunnan Baiyao ointment, and Yunnan Baiyao band-aid; generic drugs and natural specialty medicines in various areas, such as physical fitness, respiratory ailments, cardiovascular health, gynecology, pediatrics, and others; medical devices; tea products; and pharmace...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1902
• Employees: 9,286
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000538

Financial Performance

In 2025, SHE:000538's revenue was 41.19 billion, an increase of 2.88% compared to the previous year's 40.03 billion. Earnings were 5.15 billion, an increase of 8.51%.

Analyst Summary

According to 12 analysts, the average rating for 000538 stock is "Buy." The 12-month stock price target is ¥67.86, which is an increase of 32.93% from the latest price.

Price Target

¥67.86

(32.93% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 18, 2026

Data Sources Report a data error